The drugmaker will instead focus pandemic research on treatments, with initial efficacy data on an experimental oral antiviral expected by the end of March.The drugmaker will instead focus pandemic research on treatments, with initial efficacy data on an experimental oral antiviral expected by the end of March.Read More
